MENU
LEXX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexaria Bioscience (LEXX) Earnings Date & Reports
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology... Show more
A.I. Advisor
published Earnings
LEXX is expected to report earnings to rise 1,025.00% to -89 cents per share on November 25
Q3'26
Est.
$-0.90
Q2'26
Missed
by $0.02
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.07
Q3'25
Beat
by $0.02
The last earnings report on July 31 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 7.26K shares outstanding, the current market capitalization sits at 6.21M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
7
Web
https://www.lexariabioscience.com